OliPass Corporation
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of OLP-1002 Injections for Reducing Moderate to Severe Pain Due to Osteoarthritis in Hip and/or Knee Joint (NCT05216341) | OliPass Corporation | 2021-01-11 |
| OLP-1002 is Being Studied in the Treatment of Pain. (NCT03760913) | OliPass Corporation | 2018-11-21 |
Track OliPass Corporation automatically
Every clearance here is in the API, with alerts when new ones post.